RecruitingNCT04158479

China Extracorporeal Life Support Registry

Sponsor

Beijing Anzhen Hospital

Enrollment

20,000 participants

Start Date

Jan 1, 2017

Study Type

OBSERVATIONAL

Conditions

Heart Failure Acute Respiratory Failure Cardiogenic Shock Cardiac Arrest Acute Respiratory Distress Syndrome

Summary

Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade. This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.

Eligibility

Plain Language Summary

Simplified for easier understanding

This is a registry study in China collecting real-world data on patients who have been placed on ECMO — a life support machine that takes over the work of the heart and/or lungs when they are failing. The registry aims to understand how ECMO is being used across hospitals and which factors affect patient outcomes. **You may be eligible if...** - You are a patient receiving ECMO (extracorporeal membrane oxygenation) for heart failure, respiratory failure, or both **You may NOT be eligible if...** - You or your representative refuse to give consent for your data to be included Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEECMO

ECMO for circulatory and/or respiratory support

Locations(1)

Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04158479

Related Trials

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management

NCT074022391 location

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

NCT06991257135 locations